Metraipolis › archive › dc_0d0ca9ee462a
CD44 Targeting of Cisplatin-Loaded Hyaluronic Acid-Modified Mesoporous Silica Nanoparticles for Lung Adenocarcinoma: Synthesis, Characterization, In Vitro and… — Europe PMC PMID:41754914
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41754914
- DOI
- 10.3390/pharmaceutics18020171
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T11:39:31.775Z
- SHA-256 of the archived text
811e7993dfc03c647cfad07b444793aae1b1da0c84ec899c45d786461158d61e- Stable URL of this page
https://metraipolis.com/documento/dc_0d0ca9ee462a
How to cite
CD44 Targeting of Cisplatin-Loaded Hyaluronic Acid-Modified Mesoporous Silica Nanoparticles for Lung Adenocarcinoma: Synthesis, Characterization, In Vitro and… — Europe PMC PMID:41754914 — Europe PMC (en), https://europepmc.org/article/MED/41754914 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0d0ca9ee462a (Metraipolis archive dc_0d0ca9ee462a, sha256 811e7993dfc03c647cfad07b444793aae1b1da0c84ec899c45d786461158d61e)
BibTeX
@misc{dc0d0ca9ee462a,
title = {CD44 Targeting of Cisplatin-Loaded Hyaluronic Acid-Modified Mesoporous Silica Nanoparticles for Lung Adenocarcinoma: Synthesis, Characterization, In Vitro and… — Europe PMC PMID:41754914},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41754914},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0d0ca9ee462a; sha256 811e7993dfc03c647cfad07b444793aae1b1da0c84ec899c45d786461158d61e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41754914. Agents can read the archived copy with the MCP tool read_document.